Fenimore Asset Management Inc Raises Stock Position in Agilent Technologies, Inc. $A

Fenimore Asset Management Inc boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 594,972 shares of the medical research company’s stock after buying an additional 8,472 shares during the quarter. Agilent Technologies makes up approximately 1.7% of Fenimore Asset Management Inc’s portfolio, making the stock its 25th biggest position. Fenimore Asset Management Inc’s holdings in Agilent Technologies were worth $80,958,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of A. Brighton Jones LLC raised its stake in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares during the period. Jones Financial Companies Lllp raised its stake in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. raised its stake in Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after purchasing an additional 212 shares during the period. Acadian Asset Management LLC raised its stake in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in Agilent Technologies during the second quarter worth about $273,000.

Agilent Technologies Trading Down 0.8%

Shares of A stock opened at $114.57 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The stock has a market capitalization of $32.38 billion, a P/E ratio of 25.29, a price-to-earnings-growth ratio of 2.41 and a beta of 1.22. The company has a 50 day moving average price of $116.34 and a 200 day moving average price of $132.49. Agilent Technologies, Inc. has a fifty-two week low of $104.36 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were issued a $0.255 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on A shares. Morgan Stanley reduced their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. TD Cowen dropped their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $155.00 to $160.00 in a research report on Monday, January 5th. HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. Finally, Barclays dropped their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.